Health Secretary RFK Jr. States Insufficient Evidence Linking Tylenol Use to Autism Amid Texas Lawsuit

Health and Human Services Secretary Robert F. Kennedy Jr. has stated that there is not sufficient evidence to definitively link Tylenol use during pregnancy to autism, although he described the association as "very suggestive" and recommended a cautious approach. This marks a nuanced shift from earlier warnings by Kennedy and President Donald Trump, who had urged pregnant women to avoid Tylenol without citing clear scientific evidence. The controversy intensified after Texas Attorney General Ken Paxton sued Kenvue, Tylenol's manufacturer, alleging that the company concealed autism-related risks. Despite these claims, medical experts and the FDA acknowledge conflicting studies, and Tylenol remains widely considered safe for pregnant women when used appropriately. CDC data shows a rising autism diagnosis rate in children, which has fueled public concern and government scrutiny. Kennedy's comments reflect ongoing debate and caution amid limited conclusive research linking acetaminophen to neurodevelopmental issues.